NCT03030066View on ClinicalTrials.gov

Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas

NAActive, not recruitingINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

January 19, 2017

Primary Completion Date

January 31, 2021

Study Completion Date

August 31, 2026

Conditions

Glioma

Interventions

DRUG

DS-1001b

Generic not assigned

Trial Locations (1)

Unknown

National Cancer Center Hospital, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY